Cyclophosphamide and floxuridine adjuvant chemotherapy for stage III and IV carcinoma of the ovary.
D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D003536:Cystadenocarcinoma / Q000188:drug therapy; D003537:Cystadenoma / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality
D005467:Floxuridine; D003520:Cyclophosphamide